SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Net Change in Cash
SCI Pharmtech Inc
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Net Change in Cash
-NT$359.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Net Change in Cash
NT$240.1m
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Net Change in Cash
-NT$161.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
-34%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Net Change in Cash
NT$224.5m
|
CAGR 3-Years
105%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Net Change in Cash
NT$4.3B
|
CAGR 3-Years
232%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Net Change in Cash
-NT$516.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Net Change in Cash?
Net Change in Cash
-359.7m
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Net Change in Cash amounts to -359.7m TWD.
What is SCI Pharmtech Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-3%
The average annual Net Change in Cash growth rates for SCI Pharmtech Inc have been -6% over the past three years , and -3% over the past ten years .
You don't have any saved screeners yet